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Cemented Versus Cementless Total Knee
Arthroplasty of the Same Modern Design
A Prospective, Randomized Trial
Denis Nam, MD, MSc, Charles M. Lawrie, MD, Rondek Salih, MPH, Cindy R. Nahhas, BS,
Robert L. Barrack, MD, and Ryan M. Nunley, MD
Investigation performed at Washington University School of Medicine, St. Louis, Missouri

Background: Highly porous surfaces promoting biologic ﬁxation have renewed interest in cementless total knee
arthroplasty (TKA), but the potential for failed biologic ﬁxation remains. The purpose of this study was to compare the
clinical outcomes of cemented and cementless versions of the same TKA design at an average of 2 years postoperatively.
Methods: This was an institutional review board-approved, prospective, randomized controlled trial of patients from 18
to 75 years of age who were undergoing a primary TKA. Patients with inﬂammatory arthritis, a body mass index (BMI) of
>40 kg/m2, infection, a neuromuscular disorder, or grossly osteoporotic bone or bone defects were excluded. Patients
were randomized to receive a cemented or cementless cruciate-retaining TKA of the same design. The cementless implant
has highly porous ﬁxation surfaces. Oxford Knee, Knee Society, and Forgotten Joint Scores were collected. Patients were
asked to rate the knee with the TKA as a percentage of normal. Power analysis indicated that 130 patients were necessary
to demonstrate a 5-point difference in the Oxford Knee Score at 90% power.
Results: One hundred and forty-seven patients were enrolled, and 141 (96%) of them were analyzed at an average of 2
years postoperatively. There was no difference in age, sex, BMI, American Society of Anesthesiologists (ASA) score, or
duration of follow-up (p = 0.1 to 0.9). There was also no difference in the change in the hemoglobin level from the
preoperative measurement to postoperative day 1 between the 2 cohorts (mean and standard deviation, 22.6 ± 1.4 g/dL
compared with 22.5 ± 0.9 g/dL, p = 0.5), but the total operative time was decreased in the cementless cohort (82.1 ±
16.6 compared with 93.7 ± 16.7 minutes, p = 0.001). There were no differences in any clinical outcome measure at 4 to 6
weeks, 1 year, or an average of 2 years postoperatively (p = 0.1 to 0.9) between the cemented and cementless cohorts.
There was no radiographic evidence of component subsidence or loosening in either cohort.
Conclusions: This study demonstrated that a recently introduced cementless TKA had results, both perioperatively and
at an average of 2 years postoperatively, that were equivalent to those of its cemented predecessor, without any aseptic
failures of either implant. Thus, this study justiﬁes continued surveillance of this device to elucidate both its survivorship
and if it can provide any long-term beneﬁts.
Level of Evidence: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.

A

septic component loosening remains the most common
indication for revision total knee arthroplasty (TKA)1.
Thus, despite the excellent survivorship and clinical

outcomes of TKA2,3, component ﬁxation remains a long-term
concern. The number of primary TKAs performed annually
in the United States is increasing at an exponential rate, with
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an increasing percentage of younger patients seeking TKA4. The
rate of aseptic component loosening is known to be greater in
younger patients5,6; thus, the potential impact of this growing
demographic on the rate of aseptic component loosening is a
concern.
The optimal mode of ﬁxation in TKA has been an area
of debate for decades. Cementless prostheses remain an intriguing option because of the potential for biologic ﬁxation
and improved survivorship7. However, numerous prior reports
of cementless TKA designs have raised concerns regarding
failure of ﬁxation, early failure, and poor clinical outcomes7-11.
Furthermore, the immediate ﬁxation and excellent survivorship of cemented TKA make transitioning from this technique difﬁcult for the majority of surgeons11. Lastly, cementless
prostheses are typically more expensive than their cemented
counterparts, which can impact a surgeon’s choice of the mode
of ﬁxation.
Most early iterations of cementless implants had numerous design ﬂaws, including the use of sintered beads or mesh
coating, non-continuous ﬁxation surfaces, poor polyethylene
locking mechanisms and sterilization methods, and the use
of metal-backed patellae known to have poor survivorship12.
However, the clinical success of highly porous surfaces in total
hip arthroplasty has stimulated an increased interest in their
application to cementless TKA designs13. Numerous studies have
demonstrated encouraging results with the use of modern cementless designs13-17. However, despite the use of highly porous
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surfaces, concerns about suboptimal ﬁxation and worse clinical
outcomes remain. Furthermore, not all implants with highly
porous surfaces are the same, as numerous factors such as
implant metallurgy, stiffness, surface coatings, and keel or peg
ﬁxation design can greatly inﬂuence outcomes. It remains necessary to analyze the results of recently introduced prosthetic
designs to determine if poor outcomes would warrant their
discontinuation.
Recently, a cementless TKA implant was introduced with
design features similar to those of its cemented predecessor, but
it has a highly porous titanium coating applied by 3-dimensional
printing to encourage biologic ﬁxation of the tibial component.
The purpose of this prospective, randomized study was to
determine if there are any differences in perioperative variables or clinical or radiographic outcomes between cemented
and cementless TKAs of the same design.
Materials and Methods
his study was an institutional review board-approved,
prospective, randomized trial performed at a single academic institution and registered in ClinicalTrials.gov (identiﬁer: NCT03683992). Inclusion criteria were an age between
18 and 75 years, a primary TKA for a diagnosis of arthritis,
and the patient’s willingness to be randomized to be treated
with a cemented or cementless TKA implant. Exclusion criteria were a diagnosis of inﬂammatory arthritis, a body mass
index (BMI) of >40 kg/m2, active or suspected infection in the

T

Fig. 1

Flow diagram demonstrating enrollment in the cemented and cementless cohorts.
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joint or body, prior fracture of the knee (patella, femur, or
tibia), prior open surgery of the knee, a neuromuscular disorder, or grossly osteoporotic bone or bone defects seen on
preoperative radiographs. From February 2014 to November
2016, patients meeting these criteria were randomized using
computer-generated sequencing to receive either a cemented
or a cementless cruciate-retaining Triathlon TKA implant
(Stryker) (Fig. 1). Randomization and consent were overseen
by a dedicated study coordinator. Four fellowship-trained total
joint arthroplasty surgeons performed all TKAs. Each surgeon
had a 1:1 block-randomization table with random block sizes
to ensure similar group sizes for each surgeon while maintaining unpredictability of the randomization scheme. Baseline
demographics were recorded.
Perioperative protocols were the same for all patients
enrolled in this investigation. Patients received a multimodal
pain management regimen that included use of a regional anesthetic and periarticular injection. Patients received 1 g of intravenous tranexamic acid (TXA) at the time of incision and at the
start of wound closure18. Patients with a history of thromboembolic disease received 2 g of intra-articular TXA. Intra-articular
drains were not used. A pneumatic thigh tourniquet was used
only for patients receiving a cemented prosthesis. Exsanguination with an Esmarch bandage was performed prior to the skin
incision; then the tourniquet was deﬂated after cementation of
the prosthesis and prior to wound closure. The total operative
time (from incision start to wound closure), estimated blood loss

Fig. 2-A

C E M E N T E D V E R S U S C E M E N T L E S S T O TA L K N E E A R T H R O P L A S T Y
THE SAME MODERN DESIGN

OF

based on the anesthesia record, and change in hemoglobin level
(g/dL) from preoperatively to the morning of postoperative day
1 were recorded.
All patients received a cruciate-retaining prosthesis. In the
cemented cohort, the femoral and tibial components were both
ﬁxed utilizing Simplex bone cement (Stryker) (Figs. 2-A and
2-B). The cementless prosthesis (Figs. 3-A and 3-B) consists of a
beaded, Peri-Apatite-coated (Stryker) femoral component that
incorporates multiple layers of cobalt-chromium beads and has
a porosity of 40% and a mean pore size of 0.45 mm as measured
by mean intercept length, creating a 3-dimensional (3-D) surface19. Medial and lateral distal pegs are present in this cruciateretaining design for additional stability. The cementless tibial
component (Triathlon Tritanium tibial baseplate; Stryker) has a
highly porous titanium coating applied by 3-D printing to create
a biologic ﬁxation surface. A delta-shaped (triangular) keel and
4 cruciform pegs coated solely at the base of each peg are used
for ﬁxation19. Patellar resurfacing was not performed in either
cohort.
The primary outcome was the Oxford Knee Score20, which
was collected preoperatively, at 4 to 6 weeks, at 1 year, and at an
average of 2 years postoperatively. It should be noted that the
original primary outcome, as listed in ClinicalTrials.gov, was
“total tourniquet time,” but this could not be used when we
elected not to utilize tourniquets in the cementless cohort.
Secondary outcome measures included the Knee Society
Score21 and the Forgotten Joint Score22 (a measurement of a

Fig. 2-B

Figs. 2-A and 2-B Anteroposterior (Fig. 2-A) and lateral (Fig. 2-B) radiographs demonstrating an implanted cemented prosthesis.
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Fig. 3-A
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Fig. 3-B

Figs. 3-A and 3-B Anteroposterior (Fig. 3-A) and lateral (Fig. 3-B) radiographs demonstrating an implanted cementless prosthesis.

patient’s ability to forget about the joint as a result of surgical
treatment), which were also collected at 4 to 6 weeks, 1 year,
and an average of 2 years postoperatively. At 4 to 6 weeks
postoperatively, the patients were also asked to grade their
pain using a visual analog scale (VAS) ranging from 1 to 5,
with 5 being “pain that wakes you up at night, or pain all the
time.”23 In addition, patients were asked to grade their knee
with the TKA as a percentage of “normal” (maximum, 100%
[equivalent to completely normal]) at all 3 time points and
rate their overall health (maximum, 100 [equivalent to the
best possible health state]) and describe their satisfaction with
the overall function of their TKA (extremely satisﬁed, very
satisﬁed, quite satisﬁed, somewhat satisﬁed, not satisﬁed, or
uncertain) at an average of 2 years. Several secondary outcome measures (University of California Los Angeles [UCLA]
Activity Score, Short Form-12, and EuroQol-5 Dimensions
Questionnaire) that were listed in ClinicalTrials.gov were
ultimately not used in the study as we were concerned about
fatiguing our patients—i.e., we thought that giving them too
many surveys would limit their ability to answer all questions accurately.
Clinical radiographs were reviewed at 4 to 6 weeks,
1 year, and an average of 2 years postoperatively. Radiolucencies
at the bone-implant interface were measured using the method
described by Akizuki et al.24. The thickness of clear zones
between the femoral and tibial implants and bone was measured in speciﬁc regions of the anteroposterior and lateral
radiographs. Then the thicknesses in these regions were summed to calculate a total for each bone (the femur and tibia), and
the total was divided by the number of regions to calculate the
mean width of the clear zone in that bone.

Statistical Analysis
A power analysis demonstrated that a total sample size of 130
patients was needed to show a difference in the mean Oxford
Knee Scores of 5 points at 90% power, accepting a type-I error
rate of 5%. A 5-point difference in the Oxford Knee Score has
previously been reported to be the minimal clinically important difference25. In order to account for potential noncompliance with follow-up, 15% was added to our sample size, for a
total of 150 patients, and 237 patients (not a sequential series of
cases) were approached for enrollment (Fig. 1). Ninety of these
patients were not enrolled because they declined to participate
(n = 50), because they did not meet inclusion criteria (n = 37),
or for other reasons (n = 3). During the study period, the

TABLE I Comparison of Baseline Demographics and Duration
of Follow-up Between the Cemented and Cementless
Cohorts
Cemented
(N = 65)

Cementless
(N = 76)

P Value

63.0 ± 7.6

61.3 ± 7.0

0.1

Sex (% female)

52

48

0.1

BMI* (kg/m2)

31.3 ± 4.7

31.1 ± 5.2

0.8

2.1 ± 0.6

2.1 ± 0.5

0.9

24.9 ± 3.3

25.2 ± 3.9

0.6

Age* (yr)

ASA score*
Duration of
follow-up* (mo)

*The values are given as the mean and standard deviation. ASA =
American Society of Anesthesiologists.
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TABLE II Comparison of Intraoperative and Perioperative
Variables Between the Cemented and Cementless
Cohorts

Operative
time (min)
Estimated blood
loss (mL)

Cemented*
(N = 65)

Cementless*
(N = 76)

P Value†

93.7 ± 16.7

82.1 ± 16.6

0.001

185.2 ± 134.9

183.3 ± 146.7

0.9

Hemoglobin (g/dL)
Preoperative

13.6 ± 1.3

14.2 ± 1.4

0.01

Postoperative

11.1 ± 1.2

11.6 ± 1.4

0.03

Change

22.5 ± 0.9

22.6 ± 1.4

0.5

*The values are given as the mean and standard deviation.
†Signiﬁcant p values are noted in bold.

TABLE III Comparison of Pain Scores Between the Cemented
and Cementless Cohorts at 4 to 6 Weeks
Postoperatively

No pain (%)
VAS score* (1-5)

Cemented
(N = 65)

Cementless
(N = 76)

P Value

31

34

0.7

3.5 ± 1.4

3.2 ± 1.1

0.3

*The values are given as the mean and standard deviation.

participating surgeons performed approximately 1,150 TKAs,
and each screened their patients for eligibility for the investigation on the basis of exclusion criteria. If deemed suitable by
the surgeon, the patient was asked by the surgeon if he or she
would be willing to participate in a randomized controlled trial
comparing cemented and cementless prostheses. Of these
patients, 237 initially stated they were willing to participate and
willing to discuss the investigation with the study coordinator,
and 147 of them were enrolled. Patients who were unwilling to
be part of this prospective, randomized controlled trial were
still eligible to receive the cemented or cementless prosthesis at
each surgeon’s discretion. The outcomes of these patients were
retrospectively reviewed and have been previously published26.
Only as-treated analyses were conducted for all comparisons as there were no crossovers between the cemented and
cementless cohorts requiring an intent-to-treat analysis.
Independent-samples t tests were used to assess group differences in continuous variables, and Pearson chi-square tests
were used to assess categorical variables. A p value of <0.05 was
considered signiﬁcant. All statistical analyses were performed
using SPSS for Windows, version 22 (IBM).
Results
ne hundred and forty-seven patients (67 cemented and 80
cementless prostheses) were enrolled in this prospective,

O
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randomized trial. One hundred and forty-one patients (96%)
(65 cemented and 76 cementless prostheses) had complete
clinical and radiographic follow-up at an average of 2 years
postoperatively. There were no differences in baseline demographics or duration of follow-up between the cemented and
cementless cohorts (Table I).
The mean total operative time (and standard deviation)
in the cementless cohort was 82.1 ± 16.6 minutes, which was
signiﬁcantly less (p = 0.001) than that in the cementless cohort
(93.7 ± 16.7 minutes), but there were no differences in perioperative blood loss (p = 0.9) or change in hemoglobin level
from preoperatively to day 1 postoperatively (p = 0.5) between
the 2 groups (Table II).
Both at 4 to 6 weeks and at 1 year postoperatively, there
were no differences between the 2 cohorts in terms of the
Oxford Knee Score, Knee Society Score, Forgotten Joint Score,
or rating of the knee with the TKA as a percentage of “normal”
(p = 0.1 to 0.9) (Tables III, IV, and V). Of note, at 4 to 6 weeks
postoperatively, there was also no difference in the percentage
of patients who reported “no pain” (31% in the cemented
group and 34% in the cementless group, p = 0.7) or in the
mean VAS score (Table III). At 1 year postoperatively, no TKAs
in either cohort required a revision surgical procedure and
there were no radiographic ﬁndings of component subsidence
or failure.
At an average of 2 years postoperatively, there were
again no differences in any clinical outcome measure between
the 2 groups (Table VI). Approximately 68% of the patients in
the cemented cohort and 75% in the cementless cohort were
“extremely” or “very” satisﬁed with the function of their knee
(p = 0.7). Patients in the cemented cohort rated their knee to
be 88.2% ± 12.0% of “normal” compared with 87.4% ± 14.5%
in the cementless cohort (p = 0.7). Similarly, there was no difference in the postoperative overall health rating between the
2 groups (81.1 ± 13.9 and 82.3 ± 13.9, p = 0.6).

TABLE IV Comparison of Clinical Outcome Scores Between
the Cemented and Cementless Cohorts at 4 to
6 Weeks Postoperatively
Cemented*
(N = 65)

Cementless*
(N = 76)

Preoperative

23.6 ± 6.5

21.5 ± 8.1

0.1

Postoperative

24.5 ± 8.9

23.8 ± 8.9

0.3

0.9 ± 9.1

2.1 ± 9.2

0.4

P Value

Oxford Knee Score

Change
Knee Society Score
Preoperative

43.2 ± 13.6

39.3 ± 16.6

0.2

Postoperative

41.7 ± 18.0

41.4 ± 17.3

0.9

Change

21.3 ± 19.2

1.8 ± 18.1

0.3

Forgotten Joint Score

24.1 ± 22.5

24.1 ± 26.0

>0.9

% of normal knee

65.1 ± 19.0

64.2 ± 18.0

0.8

*The values are given as the mean and standard deviation.
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TABLE V Comparison of Clinical Outcome Scores Between the
Cemented and Cementless Cohorts at 1 Year
Postoperatively
Cemented*
(N = 65)

Cementless*
(N = 76)

P Value

0.1

Oxford Knee Score
Preoperative

23.6 ± 6.5

21.5 ± 8.1

Postoperative

37.4 ± 10.4

39.3 ± 8.7

0.3

Change

14.5 ± 11.2

17.4 ± 9.4

0.1

43.2 ± 13.6

39.3 ± 16.6

0.2

Knee Society Score
Preoperative
Postoperative

72.4 ± 16.3

76.7 ± 19.1

0.2

Change

31.3 ± 18.5

35.6 ± 19.8

0.2

Forgotten Joint Score

58.5 ± 25.5

60.5 ± 25.1

0.6

% of normal knee

85.1 ± 15.7

88.7 ± 10.2

0.1

*The values are given as the mean and standard deviation.

TABLE VI Comparison of Clinical Outcome Scores Between the
Cemented and Cementless Cohorts at 2 Years
Postoperatively
Cemented
(N = 65)

Cementless
(N = 76)

P Value

Oxford Knee Score*
Preoperative

23.6 ± 6.5

21.5 ± 8.1

0.1

Postoperative

39.6 ± 9.1

41.0 ± 7.5

0.3

Change

17.3 ± 10.5

19.7 ± 8.7

0.2

Knee Society Score*
Preoperative

43.2 ± 13.6

39.3 ± 16.6

0.2

Postoperative

75.6 ± 17.9

78.5 ± 17.5

0.3

33.5 ± 19.7

39.2 ± 25.2

0.2

Forgotten Joint Score*

66.6 ± 33.0

61.5 ± 31.1

0.3

% of normal knee*

88.2 ± 12.0

87.4 ± 14.5

0.7

Change

Overall health rating*
Preoperative

74.5 ± 17.0

74.4 ± 15.3

0.9

Postoperative

81.1 ± 13.9

82.3 ± 13.9

0.6

7.0 ± 19.9

8.8 ± 19.2

0.6

Change
Satisfaction with
overall function (%)

0.7

Extremely

37

41

Very

31

34

Quite

11

5

Somewhat

6

5

Slightly

0

3

Not

6

4

Uncertain

9

8

*The values are given as the mean and standard deviation.

Radiographic analysis showed no progressive radiolucencies or signs of component subsidence or failure at an average
of 2 years postoperatively. The mean thickness of the clear zones
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around the tibial component was 0.01 ± 0.01 mm in the cemented cohort compared with 0.02 ± 0.03 mm in the cementless
cohort (p = 0.01). The mean thicknesses of the clear zones
around the femoral component were 0.01 ± 0.02 and 0.02 ±
0.02 mm, respectively (p = 0.01). One revision procedure was
performed in the cemented cohort for periprosthetic infection
whereas no revisions were performed in the cementless cohort.
Discussion
septic loosening accounts for 31% to 39% of indications
for revision TKA1,27. Thus, methods to potentially improve
implant survivorship continue to be investigated. Prior iterations
of cementless implants had numerous design ﬂaws contributing
to the increased failure rates seen with their use compared with
their cemented counterparts7-11. The advent of highly porous
surfaces with properties resembling trabecular bone has shown
promising early results13,16,17,28. However, concerns about failure
of ﬁxation with cementless knee prostheses remain. The purpose
of this study was to compare a recently introduced cementless
TKA with its cemented predecessor. At an average of 2 years
postoperatively, nearly identical clinical results were achieved
using this cementless design, without any cases of aseptic failure.
Continued surveillance is necessary to determine the potential
long-term beneﬁts of this cementless design.
Cementation continues to be the favored mode of ﬁxation in TKA by the majority of surgeons as it has demonstrated
excellent survivorship and clinical function2,3. However, the
beneﬁt of initial, rigid ﬁxation is mitigated by cement’s poor
resistance to shear and tensile forces, which can eventually
result in micromotion and component loosening19. Cementless
ﬁxation eliminates the risk of cement particles and decreases
the risk of third-body debris, while potentially forming a biologic interface that can remodel and adapt over time12,24.
Numerous investigators have reported promising early
results with the use of modern iterations of cementless TKA
incorporating highly porous surfaces16,17,28,29, with most of these
authors describing the use of Trabecular Metal (Zimmer Biomet), or tantalum, as the biologic interface. DeFrancesco et al.
reported excellent results with use of a cementless, tantalum
monoblock tibial component in patients <60 years of age,
noting no revisions related to tibial ﬁxation and an all-cause
revision rate of 6% at 10 years postoperatively30. Fricka et al.
performed a prospective, randomized trial of 100 TKAs comparing cemented and cementless prostheses that had a modular, Trabecular Metal tibial tray design16. They found higher
Knee Society Scores in the cemented cohort (96.4 compared
with 92.3, p = 0.03) and a higher rate of radiolucencies in the
cementless cohort. Furthermore, there were 4 cases of varus
tibial subsidence in the cementless cohort, with a mean change
in position of 3° at 2 years postoperatively. Although these
components were believed to stabilize, continued follow-up is
necessary to determine their long-term stability and function.
Thus, the results of this prior investigation were not as favorable for that particular cementless design.
Unfortunately, there have been a number of recent implant
recalls and prosthetic failures in the ﬁeld of arthroplasty. Thus, it
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is critical to study any new prosthesis for early radiographic or
clinical signs of potential failure. Furthermore, given the vast
number of variables, such as implant metallurgy, surface coating,
and ﬁxation design, that can have substantial ramiﬁcations with
regard to patient outcomes, it is clear that not all cementless
designs are equivalent. This investigation focused on a recently
introduced cementless design with characteristics similar to those
of its cemented predecessor28. To our knowledge, this is the ﬁrst
prospective, randomized investigation of this implant design,
and it showed no difference in clinical outcomes between the
cemented and cementless cohorts as well as excellent results
without failure for aseptic loosening at 2 years postoperatively
in both groups. Furthermore, no clinical differences between
the 2 cohorts were appreciated at any time following implantation, starting as early as 4 to 6 weeks postoperatively. The
mean VAS score and the percentage of patients reporting no
pain at 4 to 6 weeks were the same in the 2 cohorts. Thus, the
concern about potentially increased pain during the early period,
prior to biologic ﬁxation, after cementless TKA was not borne
out by this investigation. However, given the increased cost of
cementless implant designs, the burden of proof remains with
cementless ﬁxation—i.e., it must be shown to be superior to
cement ﬁxation. Thus, despite the encouraging results found
with this cementless prosthesis, continued surveillance is necessary to determine the potential long-term beneﬁts of this design.
This study has several limitations. First, only 4 surgeons
from a single tertiary care center enrolled patients in this
investigation. Thus, these results may not be generalizable to
other centers. In addition, patients deemed to have osseous
defects or severe osteoporosis were excluded prior to enrollment at each surgeon’s discretion. Therefore, as there were strict
inclusion and exclusion criteria for study eligibility, this study’s
results should not be misinterpreted as indicating that all
patients are candidates for cementless ﬁxation. In addition, it is
important to note that, because of these exclusion criteria and
the fact that many patients were unwilling to participate, the
patients enrolled in this investigation represented a minority of
all TKAs performed during the study period. Therefore, the
generalizability of our results to other patient populations with
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different demographics is limited. Third, the duration of followup was short. Continued follow-up is necessary to ensure that
the clinical outcomes do not worsen, and differences between
the 2 cohorts do not become apparent, over time. However,
given the recent introduction of this speciﬁc cementless design,
we thought that it was critical to evaluate this device at early time
points to ensure that abnormal rates of failure or poor clinical
performance were not being overlooked.
Conclusions
This study demonstrated that the results of a recently introduced cementless TKA were equivalent to those of its cemented
predecessor, without aseptic failure in either group, both perioperatively and at an average of 2 years postoperatively. Thus,
this study justiﬁes continued surveillance of this device to
elucidate both its survivorship and whether it has any longterm beneﬁts. n
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